The novel approach of this peptide represents a major development in the care of the condition. Unlike existing medications, tirzepatide affects dual pathways – glucagon-like peptide-1 (GLP-1) and glucose-dependent https://tirzepatidepeptide209508.blogpixi.com/42423568/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment